coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Birkenhead PCN, Wirral (LAD) · Health Inequalities Profile

    PCN U99194 · NHS Cheshire and Merseyside Integrated Care Board · 15 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    97,870

    Registered population

    61.3% aged 18–64

    18.6%

    Aged 65+

    ICB 19.0% · England 17.9%

    5.8%

    Ethnic minority (non-White)

    2.8% Asian · England 9.6%

    57.5%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~45,090

    Core20 residents (est.)

    Resident basis; registered basis ~58,354 · see page 3

    16,442

    Hypertension register

    +5.26% in 3 yrs · England +5.60%

    1,432

    SMI register

    35.8% of Wirral (LAD)'s

    3,170

    COPD register

    Reviews +2.67% in 3 yrs

    Forecast to 2030

    18,664

    Hypertension patients, 2030

    +2,222 on today

    76.2%

    QRISK ≥20% on statins, 2030

    +3.40pp over 3 yrs

    4.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    2,514
    Asthma reviews leave 2,514 patients unreviewed.

    Annual asthma review coverage is 65.0% (England 65.7%) across 7,188 registered patients, which may reflect recall gaps to verify via practice audit.

    87.6%
    Age-five MMR2 coverage misses 95.0% target.

    Age-five MMR2 coverage is 7.4 pp below the 95.0% target and 4.9 pp below MMR1 (92.5%), which could reflect second-dose recall gaps.

    68.9%
    High-risk lipid therapy exceeds England benchmark.

    Lipid-lowering therapy in patients with QRISK ≥ 20% reaches 68.9% against 65.8% in Wirral, 63.2% in the ICB, and 63.6% in England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Birkenhead PCN serves 97,870 patients with 18.6% aged 65+ alongside 2,168 care beds

    Birkenhead PCN registers 97,870 patients. Older people aged 65+ comprise 18.6% of the list (England 17.9%; Wirral 20.7%; ICB 19.0%), while children aged 0-17 make up 20.1% (England 19.6%; Wirral 19.0%; ICB 19.2%). Projected list growth to 2030 is 1.3% (England 2.3%; Wirral 1.2%; ICB 2.3%) under an unverified forecast methodology. Census residents are 94.2% White (England 81.1%; Wirral 95.2%; ICB 93.0%) and 5.8% ethnic minority, with Asian residents at 2.8% (England 9.6%; Wirral 2.3%; ICB 2.8%). Ethnicity reflects associated area residents, not registered patients.

    Age profile

    0–1720.1%
    18–6461.3%
    65+18.6%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White94.2%
    Asian2.8%
    Mixed1.7%
    Other0.8%
    Black0.5%

    Older people · falls rows are Wirral (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wirral LA)1,5172,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wirral LA)7531,0219552024/25
    Falls deaths, all ages, per 100,000 (Wirral LA)25.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 57.5% of registrations, spanning a 100 pp practice range

    Birkenhead PCN has 57.5% of registered patients in the Core20 cohort, well above Wirral (34.8%), the ICB (31.9%) and England (21.0%), with an average IMD decile of 3.5 against Wirral's 5.2 and England's 5.5. Across practices, Core20 share spans a 100 pp range, from 0.0% at Holmlands Med Ctr to 100.0% at Hamilton Med Ctr. While smaller practices reach 100.0% concentration, patient volume concentrates in St Catherine's Surgery (11,263) and Miriam Primary Care Group (10,018). Reconciling the 58,354 practice sum with the 45,090 resident estimate must precede outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Hamilton Med Ctr100.0% · 3,030 patients
    Vittoria Med Ctr100.0% · 4,104 patients
    Vittoria Med Ctr100.0% · 1,857 patients
    Gladstone Med Ctr94.5% · 3,456 patients
    Whetstone Lane94.5% · 8,205 patients
    Cavendish88.9% · 4,925 patients
    Riverside84.9% · 7,273 patients
    St Catherine's72.0% · 11,263 patients
    Miriam Primary61.4% · 10,018 patients
    Devaney Med Ctr50.6% · 4,022 patients
    Villa3.3% · 201 patients
    Holmlands Med Ctr0.0% · 0 patients
    Kings Lane0.0% · 0 patients
    Teehey Lane0.0% · 0 patients
    Church Road0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,432

    SMI register

    1.45% recorded prevalence

    875

    Learning disability register

    0.89% recorded prevalence

    69

    Care homes, 2,168 beds

    In the PCN catchment

    10.9%

    Provide unpaid care

    Wirral (LAD), Census 2021

    Birkenhead PCN records 1,432 patients on its severe mental illness register (1.4%; England 1.0%; Wirral 1.2%; ICB 1.1%) and 875 on its learning disability register (0.9%; England 0.6%; Wirral 0.8%; ICB 0.6%). The PCN catchment includes 2,168 beds across 69 care homes. Recorded prevalence above England is consistent with substantial review demand, though care beds do not establish resident registrations.

    Severe mental illness: physical health checks

    Birkenhead PCN records 1.4% SMI prevalence. Annual checks lag England: BMI recording is 77.4% (England 82.1%), BP checks are 82.0% (England 83.4%), and alcohol recording fell 1.5 pp over three years (England +5.4 pp) to 78.7%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    16,442

    Hypertension register

    +5.26%

    Register growth, 3 yrs

    Wirral (LAD) +6.35% · England +5.60%

    +1.31pp

    BP control, under 80

    ≤140/90 · −0.64pp aged 80+

    +2,222

    More patients by 2030

    Forecast 18,664 (18.49%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 16.7% (16,442 patients), above England (15.2%) and in line with the ICB (16.8%), though below Wirral (18.0%). Hypertensive patients with a recent blood pressure check reach 89.3% (England 90.0%), having fallen 0.3% over three years (England +3.6%; ICB +2.6%). Overall blood pressure control to target is 68.2% (England 70.3%), with control under age 80 at 65.9% (England 67.8%). Lagging monitoring and control relative to England suggest active recall and titration could be audited to improve control.

    Lipids and statins

    Lipid-lowering therapy reaches 68.9% in patients with QRISK ≥ 20%, exceeding England (63.6%) and Wirral (65.8%), alongside 87.5% statin coverage in diabetes with cardiovascular disease (England 84.4%). Higher lipid coverage than England shows strong secondary and primary prevention reach that PCN practices should sustain.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026203,654£2.00£1.71£1.86£407,308
    Cardiovascular (all), 2025270,603£5.03£4.37£3.33£1,361,133

    In 2026, lipid-regulating drugs cost £2.00 per item across 203,654 items (£407,308 spend), compared to £1.86 in England and £1.71 in the ICB. This represents £28,512 more than at England's unit cost. Unit cost differences do not reflect clinical efficiency, but a formulary review could test whether cost-effective statin choices are optimised.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.81%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.89%

    Asthma prevalence, PCN 3-yr % change

    Paediatric asthma prescribing reaches 2,961 items per 1,000 aged 5-19 (England 1,488; Wirral 2,621; ICB 2,310). Asthma prevalence is 7.8% (England 6.6%), while annual review coverage of 65.0% (England 65.7%) leaves an estimated scale gap of 2,514 unreviewed patients. COPD prevalence is 3.2% (England 1.9%), with 3-year prevalence falling 0.4% (England +2.6%) and annual reviews at 74.3% (England 76.4%). Review patterns could reflect unverified recall shortfalls to audit locally.

    Cancer register and children's immunisation

    Cancer prevalence is 4.0% (England 3.8%; Wirral 4.8%). In Q1 2025/26, childhood immunisations missed the 95.0% standard across cohorts. Dose 1 MMR at 24 months reached 85.0% (England 88.3%). By age 5, MMR dose 2 reached 87.6%, below dose 1 (92.5%) by 4.9 pp, while 4-in-1 booster coverage was 83.8% (England 80.9%). This same-cohort gap could reflect delayed scheduling, which local audit would test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.9%

    England 91.0%

    6-in-1 complete primary course at 24 months90.7%

    England 92.2%

    MMR dose 1 at 24 months85.0%

    England 88.3%

    MMR dose 2 at age 587.6%

    England 82.8%

    4-in-1 pre-school booster at age 583.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB, 55.5% of staged cancers were diagnosed at stage 1 or 2 in 2022 (up 2.6 pp from 52.8% in 2013), sitting 19.5 pp below the 75.0% national ambition. Sizing this gap indicates about 2,640 extra early diagnoses are required annually, where known stage share sits 2.2 pp below the 75.0% national ambition. Locally, Birkenhead PCN records 64.7% breast screening coverage (Wirral 72.6%; England 69.9%) and 68.0% cervical screening coverage (Wirral 71.5%; England 66.8%), trailing at Whetstone Lane Med Ctr (57.0%), Hamilton Med Ctr (58.7%), and Gladstone Med Ctr (60.3%). Lower screening coverage may delay early detection across local practices.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Wirral University Teaching Hospital NHS Foundation Trust, 62-day cancer referral to treatment was 77.647% (standard 85.0%), 28-day faster diagnosis was 74.7058% (standard 75.0%), and 31-day combined treatment was 92.5266% (standard 96.0%). Across NHS Cheshire and Merseyside Integrated Care Board, 62-day performance was 76.232% (standard 85.0%), 28-day faster diagnosis was 77.2451% (standard 75.0%), and 31-day combined treatment was 95.7087% (standard 96.0%). These trust and ICB cancer waiting times describe wider secondary care performance rather than PCN delivery.

    Pathways within standard (%)WirralLiverpoolMersey and West LancashireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)74.7175.4772.3977.2579.32
    31-day treatment (96%)92.5390.5195.4695.7192.50
    62-day referral to treatment (85%)77.6573.2677.9676.2371.16
    Diagnostic waits over 6 weeks (%)WirralLiverpoolMersey and West LancashireEngland
    MRI1.546.4214.0421.40
    CT1.550.7113.089.92
    Echocardiography5.0712.5534.8828.48
    Colonoscopy32.8133.1418.0430.83
    Gastroscopy17.7344.9918.1729.02
    All 15 DM01 tests5.0211.5021.1723.14
    Community services activityWirral residentsCheshire and Merseyside ICB
    Care contacts58,870541,280
    Referrals13,31597,150
    Patients with a contact17,205146,240

    Community services (residents of Wirral), Jun 2026 (provisional). In Wirral, 66.1% of community service contacts were with adults aged 65 and over (38,930 of 58,870 contacts in provisional Jun 2026 data). Activity is captured only for borough residents, with no PCN or provider breakdown. These borough figures describe wider system activity and cannot be extrapolated to PCN delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 48.0 pp while vaccination achievement varies by 84.4 pp

    In 2025/26, the England benchmark for QOF overall achievement was 92.5%. Devaney Med Ctr achieved 76.6% overall achievement, while Hamilton Med Ctr achieved 99.9%. In the QOF vaccination and immunisation domain, the England benchmark was 55.2%. Gladstone Med Ctr achieved 15.6% domain achievement, whereas Hamilton Med Ctr achieved 100.0%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Villa1213.377.3%67.1%97.4%
    Kings Lane1300.058.2%62.3%94.5%
    Hamilton Med Ctr109100.082.3%72.6%91.0%
    Cavendish9788.970.4%74.1%90.6%
    Vittoria Med Ctr K100100.089.9%61.0%89.6%
    Church Road1220.087.8%75.3%89.1%
    Holmlands Med Ctr980.084.6%77.5%88.6%
    Teehey Lane1040.083.7%80.0%84.9%
    Miriam Primary12261.461.9%84.6%83.9%
    Riverside Surgery10784.971.6%79.8%82.0%
    Whetstone Lane9094.566.4%61.9%80.4%
    St Catherine's12472.046.2%56.1%80.0%
    Devaney Med Ctr9550.642.0%63.3%74.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWirral (LAD)AssetPCNWirral (LAD)
    Care homes (catchment)69 (2,168 beds)n/aSchools (catchment)106n/a
    Children's centres916Places of worship91171
    Libraries718Primary schools (LA maintained)2852
    Primary academies1736Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma review coverage is 65.0% (England 65.7%; 3-year change +2.8% vs England +4.4%) across 7,188 patients (7.8% prevalence), leaving a scale gap of 2,514 patients. For discussion: practices could run a single-template asthma review and inhaler check recall, offering after-school slots at high-concentration and high-volume Core20 surgeries. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    In Q1 2025/26 (cohort 241), age-5 MMR2 is 87.6% (below the 95.0% target by 7.4 pp; below MMR1 at 92.5% by 4.9 pp) and 4-in-1 booster coverage is 83.8% (below 95.0% by 11.2 pp). Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Hypertension and SMI check recall

    Hypertension control is 68.2% (England 70.3%) across 16,442 patients (16.7%; Wirral 18.0%, modelled gap range -1,537 to +1,204). SMI BP checks reach 82.0% (Wirral 85.6%) and BMI 77.4% (England 82.1%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Ethnicity recording and access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 2 coverage at age 5 · MMR dose 1 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Hypertension and SMI check recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029 · MHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15